Soluble NKG2D ligands in hepatic autoimmune diseases and in benign diseases involved in marker metabolism

Keyphrases

• Metabolism 100%
• Autoimmune Disease 100%
• NKG2D 100%
• Benign Disease 100%
• SMICA 100%
• Renal Insufficiency 50%
• Acute Infection 50%
• Cholestasis 50%
• Serum Levels 33%
• Healthy Controls 16%
• Primary Sclerosing Cholangitis 16%
• Organ-specific 16%
• In Cancer 16%
• Cancer Cells 16%
• Healthy Individuals 16%
• Immune Escape 16%
• Autoimmune Hepatitis 16%
• Diagnostic Potential 16%
• Antitumor 16%
• Immunostimulatory 16%
• Cancer Disease 16%
• Elevated Concentrations 16%
• Primary Biliary Cirrhosis 16%
• Escape Strategy 16%
• Soluble MICA 16%
• Cytotoxic Lymphocytes 16%
• Proteolytic Shedding 16%
• General Impact 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Autoimmune Disease 100%
• Diseases 100%
• Kidney Failure 75%
• Cholestasis 75%
• Malignant Neoplasm 50%
• Bacterial Infection 50%
• Enzyme-Linked Immunosorbent Assay 25%
• Autoimmune Hepatitis 25%
• Infection 25%
• Primary Sclerosing Cholangitis 25%
• Primary Biliary Cirrhosis 25%

Immunology and Microbiology

• NKG2D 100%
• Autoimmune Disease 100%
• Blood Level 50%
• Immune Escape 25%
• Cytotoxic Lymphocyte 25%
• Cancer Cell 25%
• ELISA 25%
• Primary Sclerosing Cholangitis 25%
• Autoimmune Hepatitis 25%
• Primary Biliary Cirrhosis 25%